STOCK MARKET BSE NSE

Availability of COVID vaccine for kids will pave way for school reopening: AIIMS chief Dr Randeep Guleria

Dr Randeep said the data of phase two and three trial of Covaxin on two to 18 years age group is expected by September.

Published: 27th June 2021 05:53 PM  |   Last Updated: 27th June 2021 05:56 PM   |  A+A-

COVID Vaccine

For representational purposes (Photo | PTI)

By PTI

NEW DELHI: Making COVID-19 vaccine available for children will be a milestone achievement and pave the way for reopening of schools and resumption of outdoor activities for them, AIIMS Chief Dr Randeep Guleria has said.

He said the data of phase two and three trial of Bharat Biotech's Covaxin on two to 18 years age group is expected by September.

The vaccine can be available for children in India around that time following approval from the drug regulator, he said.

"If the Pfizer vaccine gets approval before that, then it can also be an option for children," Dr Guleria told PTI on Saturday.

According to a senior government official, pharmaceutical major Zydus Cadila is also likely to soon apply to the Drugs Controller General of India for emergency use authorisation for its COVID-19 vaccine ZyCoV-D, which it claims can be given to both adults and children.

"So, if the Zydus vaccine gets approval, it will be another option," Dr Guleria said.

ALSO WATCH: How Mumbai, India's most crowded city, beat the odds, and the coronavirus

He stressed that though children mostly have mild infections of COVID-19 and some even are asymptomatic, they can be carriers of the infection.

Underscoring that there has been a major loss in studies in the last one-and-half years on account of the COVID-19 pandemic, the AIIMS chief said, "Schools have to be reopened and vaccination can play an important role in that."

Vaccination is the way out from the pandemic, he said.

The government has recently cautioned that even though COVID-19 has not impacted children greatly till now, that can increase if there is a change in the behaviour of the virus or in epidemiology dynamics.

It said that preparations are being made to deal with any such situation.

A national expert group has been formed to review COVID-19 infections among children and approach the pandemic in a new way and reinforce the nation's preparedness for it.

On the issue of vaccinating children, NITI Aayog member (Health) Dr V K Paul recently said, "Child cohort is not a small one. My rough guess is that if it is between 12 to 18 years, this itself is about 13 to 14 crore population for which we will need about 25-26 crore doses."

He further shared that not only Bharat Biotech's Covaxin, Zydus Cadila's vaccine is also being tested on children.

"So when Zydus comes for licensure soon, maybe we have enough data to take a view on whether the vaccine can be given in children," Paul said.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp